HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

New drugs for myeloid neoplasms with ring sideroblasts: Luspatercept vs imetelstat.

AuthorsAyalew Tefferi
JournalAmerican journal of hematology (Am J Hematol) Vol. 96 Issue 7 Pg. 761-763 (07 01 2021) ISSN: 1096-8652 [Electronic] United States
PMID33861878 (Publication Type: Journal Article)
Chemical References
  • Immunoglobulin Fc Fragments
  • Oligonucleotides
  • Recombinant Fusion Proteins
  • luspatercept
  • Activin Receptors, Type II
  • imetelstat
Topics
  • Activin Receptors, Type II (therapeutic use)
  • Drug Approval
  • Drug Discovery
  • Humans
  • Immunoglobulin Fc Fragments (therapeutic use)
  • Myelodysplastic Syndromes (drug therapy, pathology)
  • Myelodysplastic-Myeloproliferative Diseases (drug therapy, pathology)
  • Oligonucleotides (therapeutic use)
  • Recombinant Fusion Proteins (therapeutic use)
  • Thrombocytosis (drug therapy, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: